Literature DB >> 7969113

Transcriptional regulation of NF-kappa B2: evidence for kappa B-mediated positive and negative autoregulation.

S Liptay1, R M Schmid, E G Nabel, G J Nabel.   

Abstract

NF-kappa B is an inducible transcription factor complex which regulates the expression of a variety of genes which are involved in the immune, inflammatory, and acute-phase responses. The maintenance of NF-kappa B activity in stimulated cells requires ongoing protein synthesis, suggesting several modes of regulation. In this report, we have characterized the transcriptional regulation of one family member, NF-kappa B2. The genomic structure and sequence of NF-kappa B2 revealed the presence of two promoters and at least four kappa B regulatory elements, which mediate responsiveness to phorbol myristate acetate and tumor necrosis factor alpha. Similar to other NF-kappa B family members, NF-kappa B2 is positively autoregulated. In contrast to other family members, we find that kappa B elements in the NFKB2 promoter can also mediate transcriptional repression in the absence of NF-kappa B. We identified a nuclear complex which binds specifically to a subset of kappa B-related sites but not to the canonical kappa B element. Because of its putative inhibitory or repressive effect, this binding activity has been termed Rep-kappa B. This mechanism of repressing basal NF-kappa B2 transcription in an inactivated state enables the cell to tightly control NF-kappa B2 activity. These data demonstrate that a novel mode of kappa B-dependent regulation is mediated by specific kappa B sites in the NFKB2 promoter.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969113      PMCID: PMC359311          DOI: 10.1128/mcb.14.12.7695-7703.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  24 in total

1.  The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product.

Authors:  M Kieran; V Blank; F Logeat; J Vandekerckhove; F Lottspeich; O Le Bail; M B Urban; P Kourilsky; P A Baeuerle; A Israël
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

2.  Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B.

Authors:  S M Ruben; P J Dillon; R Schreck; T Henkel; C H Chen; M Maher; P A Baeuerle; C A Rosen
Journal:  Science       Date:  1991-03-22       Impact factor: 47.728

3.  A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon.

Authors:  E Brownell; N Mittereder; N R Rice
Journal:  Oncogene       Date:  1989-07       Impact factor: 9.867

4.  RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.

Authors:  R P Ryseck; P Bull; M Takamiya; V Bours; U Siebenlist; P Dobrzanski; R Bravo
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

5.  Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65.

Authors:  R M Schmid; N D Perkins; C S Duckett; P C Andrews; G J Nabel
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

6.  DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide.

Authors:  G P Nolan; S Ghosh; H C Liou; P Tempst; D Baltimore
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

7.  B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.

Authors:  A Neri; C C Chang; L Lombardi; M Salina; P Corradini; A T Maiolo; R S Chaganti; R Dalla-Favera
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

8.  A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site.

Authors:  V Bours; P R Burd; K Brown; J Villalobos; S Park; R P Ryseck; R Bravo; K Kelly; U Siebenlist
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

9.  Maintenance of NF-kappa B activity is dependent on protein synthesis and the continuous presence of external stimuli.

Authors:  H P Hohmann; R Remy; C Scheidereit; A P van Loon
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

10.  Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha.

Authors:  R Meyer; E N Hatada; H P Hohmann; M Haiker; C Bartsch; U Röthlisberger; H W Lahm; E J Schlaeger; A P van Loon; C Scheidereit
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

View more
  44 in total

1.  Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha.

Authors:  G Xiao; M E Cvijic; A Fong; E W Harhaj; M T Uhlik; M Waterfield; S C Sun
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

2.  RelA repression of RelB activity induces selective gene activation downstream of TNF receptors.

Authors:  Emilie Jacque; Thierry Tchenio; Guillaume Piton; Paul-Henri Romeo; Véronique Baud
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-28       Impact factor: 11.205

3.  Regulation of RelB expression during the initiation of dendritic cell differentiation.

Authors:  Pedro J Cejas; Louise M Carlson; Despina Kolonias; Jian Zhang; Inna Lindner; Daniel D Billadeau; Lawrence H Boise; Kelvin P Lee
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

4.  RelA and RelB cross-talk and function in Epstein-Barr virus transformed B cells.

Authors:  A Chanut; F Duguet; A Marfak; A David; B Petit; M Parrens; S Durand-Panteix; M Boulin-Deveza; N Gachard; I Youlyouz-Marfak; D Bordessoule; J Feuillard; N Faumont
Journal:  Leukemia       Date:  2013-09-23       Impact factor: 11.528

5.  Distamycin prolongs E-selectin expression by interacting with a specific NF-kappaB-HMG-I(Y) binding site in the promoter.

Authors:  P Ghersa; J Whelan; Y Cambet; J F DeLamarter; R Hooft van Huijsduijnen
Journal:  Nucleic Acids Res       Date:  1997-01-15       Impact factor: 16.971

6.  Preventing abnormal NF-κB activation and autoimmunity by Otub1-mediated p100 stabilization.

Authors:  Yanchuan Li; Jin-Young Yang; Xiaoping Xie; Zuliang Jie; Lingyun Zhang; Jianhong Shi; Daniel Lin; Meidi Gu; Xiaofei Zhou; Haiyan S Li; Stephanie S Watowich; Antrix Jain; Sung Yun Jung; Jun Qin; Xuhong Cheng; Shao-Cong Sun
Journal:  Cell Res       Date:  2019-05-13       Impact factor: 25.617

7.  Cytokine candidate genes predict the development of secondary lymphedema following breast cancer surgery.

Authors:  Geraldine Leung; Christina Baggott; Claudia West; Charles Elboim; Steven M Paul; Bruce A Cooper; Gary Abrams; Anand Dhruva; Brian L Schmidt; Kord Kober; John D Merriman; Heather Leutwyler; John Neuhaus; Dale Langford; Betty J Smoot; Bradley E Aouizerat; Christine Miaskowski
Journal:  Lymphat Res Biol       Date:  2014-02-06       Impact factor: 2.589

8.  Structural and functional characterization of the promoter regions of the NFKB2 gene.

Authors:  L Lombardi; P Ciana; C Cappellini; D Trecca; L Guerrini; A Migliazza; A T Maiolo; A Neri
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

9.  In vivo imaging of particle-induced inflammation and osteolysis in the calvariae of NFκB/luciferase transgenic mice.

Authors:  Kunihiko Takahashi; Shin Onodera; Harukazu Tohyama; Hyuck Joon Kwon; Ken-ichi Honma; Kazunori Yasuda
Journal:  J Biomed Biotechnol       Date:  2010-09-21

10.  Generation and activation of multiple dimeric transcription factors within the NF-kappaB signaling system.

Authors:  Soumen Basak; Vincent Feng-Sheng Shih; Alexander Hoffmann
Journal:  Mol Cell Biol       Date:  2008-02-25       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.